CEN Biotech Total Current Liabilities

CEN Biotech posts a total current liabilities of $10M as of September 2023. That compares with $9.8M in the prior-year period — up 6.7% year over year. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.

In the prior comparable period, CEN Biotech's total current liabilities was $9.8M. The latest reading is $10M — a 6.7% year-over-year increase (period ending September 2023). Use the history and growth charts on this page for a longer lookback.

Total Current Liabilities is one piece of CEN Biotech's financial statement story. At $10M, it should be interpreted next to related metrics — for example revenue with costs, assets with liabilities, or income with margins. Stockcircle links those related pages so you can move from this number to the surrounding context quickly.

Context for CENBF's total current liabilities usually means three checks: (1) trend versus prior periods, (2) level versus peers, and (3) consistency with growth and profitability. This page covers the first two; CEN Biotech's other metric pages and overview cover the third.